-
2024-512297-96-01
4
2024-11-26
Head and neck squamous cell carcinoma
-
2024-511070-68-01
5
2024-09-24
Ampullary adenocarcinoma
-
2023-508613-17-00
5
2024-05-29
Neoplasms, Head and Neck
-
2024-514101-65-00
4
2023-12-21
Multiple Myeloma
-
2024-516058-23-00
5
2023-12-18
Adult patients admitted to the ICU for management of severe influenza
-
2024-513811-29-00
5
2023-07-03
Cardiogenic Shock
-
2022-501688-42-00
5
2023-05-24
Low Grade Glioma
-
2022-501494-39-00
5
2023-03-28
Uncontrolled Hypertension IN patients with moderate to severe chronic
-
2024-511896-13-00
11
2022-12-09
EA-COPD (with mechanical ventilation, invasive or non-invasive, or hig
-
2022-500295-60-00
4
2022-09-15
Acute Myeloid Leukemia
-
2024-517215-67-00
5
2021-06-11
Newly diagnosed Non-Frail transplant Ineligible Multiple Myeloma elder
-
2024-514349-13-00
5
2020-10-11
Excision-autograft surgery in burn patient
-
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi
-
2024-516873-57-00
10
2026-01-13
Acute myeloid leukemia in adults aged 18 to 60
-
2024-512147-23-00
10
2024-11-21
Chronic Lymphocytic Leukemia
-
2023-508235-31-00
5
2024-06-17
Atopic Dermatitis
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-501024-20-00
5
2023-07-25
ER+/HER2- Early Breast Cancer
-
2024-515845-40-00
5
2022-11-22
Acute kidney injury
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-507961-24-00
5
2021-04-19
High-Risk HER2-Positive Breast Cancer
-
2023-503384-41-00
5
2020-12-22
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
-
2023-507419-37-00
5
2020-06-25
Plasma cell myeloma
-
2023-505042-25-00
5
2020-05-05
Locally advanced (inoperable) or metastatic HR+/HER2 breast cancer